Summit Therapeutics Inc. Increase (Decrease) in Other Noncurrent Assets
Summit Therapeutics Inc. (SMMT) reported Increase (Decrease) in Other Noncurrent Assets of $1.24 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-07-23
- Summit Therapeutics Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $217.00K, a 90.37% decline year-over-year.
- Summit Therapeutics Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $1.03M, a 27.70% decline year-over-year.
- Summit Therapeutics Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $856.00K.
- Summit Therapeutics Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-06-30 was $2.25M, a 56225.00% increase year-over-year.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month |
|---|---|---|---|
| 2026-06-30 | $217.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $1.24M 10-Q · filed 2026-07-23 | |
| 2026-03-31 | $1.03M 10-Q · filed 2026-04-30 | ||
| 2025-09-30 | $856.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-20 | $3.11M derived: sum of 2 quarters · filed 2026-07-23 | $4.53M 10-Q · filed 2025-10-20 |
| 2025-06-30 | $2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $3.67M 10-Q · filed 2026-07-23 | |
| 2025-03-31 | $1.42M 10-Q · filed 2026-04-30 | ||
| 2024-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-20 | -$10.00K derived: sum of 2 quarters · filed 2025-10-20 | -$2.46M 10-Q · filed 2025-10-20 |
| 2024-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$2.44M 10-Q · filed 2025-08-11 | |
| 2024-03-31 | -$2.45M 10-Q · filed 2025-05-01 | ||
| 2022-06-30 | $27.00K 10-Q · filed 2022-08-11 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |